Citation 89084

MIMAKI,Y: WATANABE,K: SAKAGAMI,H: SASHIDA,Y:. (2002). STEROIDAL GLYCOSIDES FROM THE LEAVES OF CESTRUM NOCTURNUM.. 65(12)

Citation Details

TitleSTEROIDAL GLYCOSIDES FROM THE LEAVES OF CESTRUM NOCTURNUM.
AuthorsMIMAKI,Y: WATANABE,K: SAKAGAMI,H: SASHIDA,Y:
Year2002
Volume65
Issue12

Summary

Year: 2002

Journal: Unknown

Organisms and Their Experiments (1)

Cestrum nocturnum (SOLANACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
VOUCHER SPECIMEN REPORTED FOR
NoneNone
2Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
SPIROST-5-EN-3-BETA-YL,24(S)-[(BETA-D-GLUCOPYRANOSYL)-OXY]-2-ALPHA-HYDROXY: O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE: 25(S):
None
3
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
SPIROST-5-EN-3-BETA-YL,24(S)-[(BETA-D-GLUCOPYRANOSYL)-OXY]-2-ALPHA-HYDROXY: O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE: 25(S):
INACTIVE
4Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
FUROST-5-EN-3-BETA-YL,26-[(BETA-D-GLUCOPYRANOSYL)-OXY]-2-ALPHA-HYDROXY-22-ALPHA-METHOXY: O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE: 25(R):
None
5
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
FUROST-5-EN-3-BETA-YL,26-[(BETA-D-GLUCOPYRANOSYL)-OXY]-2-ALPHA-HYDROXY-22-ALPHA-METHOXY: O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE: 25(R):
WEAK ACTIVITY
6Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
FUROSTA-5-20(22)-DIEN-3-BETA-YL,26-[(BETA-D-GLUCOPYRANOSYL)-OXY]-2-ALPHA-HYDROXY: O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE: 25(R):
None
7
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
FUROSTA-5-20(22)-DIEN-3-BETA-YL,26-[(BETA-D-GLUCOPYRANOSYL)-OXY]-2-ALPHA-HYDROXY: O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE: 25(R):
INACTIVE
8Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
PREGN-5-EN-20-ONE,2-ALPHA-HYDROXY: 3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]-16-BETA-[[4(R)-5-(BETA-D-GLUCOPYRANOSYL-OXY)-4-METHYL-1-OXO
None
9
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
PREGN-5-EN-20-ONE,2-ALPHA-HYDROXY: 3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]-16-BETA-[[4(R)-5-(BETA-D-GLUCOPYRANOSYL-OXY)-4-METHYL-1-OXO
INACTIVE
10Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
PREGNA-5-16-DIEN-20-ONE,2-ALPHA-HYDROXY: 3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]:
None
11
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
PREGNA-5-16-DIEN-20-ONE,2-ALPHA-HYDROXY: 3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]:
INACTIVE
12Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CHOLESTA-5-17-DIENE-16-22-DIONE,2-ALPHA-HYDROXY: 3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]-26-[(BETA-D-GLUCOPYRANOSYL)-OXY}: 25(R):
None
13
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
CHOLESTA-5-17-DIENE-16-22-DIONE,2-ALPHA-HYDROXY: 3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]-26-[(BETA-D-GLUCOPYRANOSYL)-OXY}: 25(R):
INACTIVE
14Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CHOLESTA-5-17-DIENE-16-22-DIONE,2-ALPHA-HYDROXY: 3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]-26-[(BETA-D-GLUCOPYRANOSYL)-OXY]: 25(R):
None
15
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
CHOLESTA-5-17-DIENE-16-22-DIONE,2-ALPHA-HYDROXY: 3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]-26-[(BETA-D-GLUCOPYRANOSYL)-OXY]: 25(R):
INACTIVE
16Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
PREGN-5-ENE-20-CARBOXYLIC ACID-GAMMA-LACTONE,2-ALPHA-16-BETA-DIHYDROXY: 3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]:
None
17
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
PREGN-5-ENE-20-CARBOXYLIC ACID-GAMMA-LACTONE,2-ALPHA-16-BETA-DIHYDROXY: 3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]:
INACTIVE
18Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
SPIROST-5-EN-3-BETA-YL,2-ALPHA-HYDROXY: O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-I-[BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE: 25(R)
None
19
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
SPIROST-5-EN-3-BETA-YL,2-ALPHA-HYDROXY: O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-I-[BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE: 25(R)
ACTIVE
20Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
SPIROST-5-EN-3-BETA-YL,2-ALPHA-17-ALPHA-DIHYDROXY: O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIE: 25(R):
None
21
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
SPIROST-5-EN-3-BETA-YL,2-ALPHA-17-ALPHA-DIHYDROXY: O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIE: 25(R):
ACTIVE
Show SPARQL Queries (1)